Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 women found that those taking GLP-1 drugs, a category that includes semaglutide-based medications like Ozempic and Wegovy, were significantly less likely to develop breast cancer. The findings…

Read Full News

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

Popular GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have already transformed the treatment of type 2 diabetes and obesity. Now, new research suggests these medications may also help prevent and treat addiction across a broad range of substances. Researchers at Washington University School of Medicine in St. Louis found that GLP-1 medications were associated…

Read Full News